News from biospecifics technologies corp A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NYSE:BLL)

Jun 27, 2014, 08:30 ET

BioSpecifics Technologies Corp. to Be Added to Russell 3000® Index

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Jun 25, 2014, 16:01 ET

BioSpecifics Technologies Corp. Announces Filing by Sobi for EU Approval of XIAPEX for Peyronies Disease

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

May 19, 2014, 17:31 ET

BioSpecifics Announces New Analyses of XIAFLEX for Peyronie's Disease Presented at American Urological Association

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed...

May 12, 2014, 08:00 ET

BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

May 08, 2014, 08:00 ET

BioSpecifics Technologies Corp. Reports First Quarter 2014 Financial Results

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

May 01, 2014, 08:30 ET

BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2014 Financial Results on Thursday, May 8, 2014

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products...

Apr 02, 2014, 08:00 ET

BioSpecifics Technologies Corp. to Present at the 13th Annual Needham Healthcare Conference

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Mar 06, 2014, 08:00 ET

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2013 Financial Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Feb 27, 2014, 08:30 ET

BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2013 Financial Results on Thursday, March 6, 2014

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Feb 19, 2014, 16:15 ET

BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed...

Jan 08, 2014, 08:30 ET

BioSpecifics Technologies Corp. Announces Positive Top-line Data from Phase 2 Clinical Trial of CCH for the Treatment of Human Lipoma

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Dec 23, 2013, 08:30 ET

BioSpecifics Technologies Corp. Announces Top-line Data from Phase 2 Trial of CCH for Canine Lipoma

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Dec 13, 2013, 08:42 ET

BioSpecifics Technologies Corp. Announces Initiation of Phase 2b Trial of CCH for Treatment of Frozen Shoulder Syndrome

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products...

Dec 12, 2013, 17:35 ET

BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Stock Repurchase Program

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Dec 06, 2013, 16:08 ET

BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX® for the Treatment of Peyronie's Disease

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Nov 18, 2013, 08:30 ET

BioSpecifics Technologies Corp. Announces Positive Top-line Data from XIAFLEX® MULTICORD Phase IIIb Study

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products marketed as...

Nov 12, 2013, 08:00 ET

BioSpecifics Technologies Corp. Reports Third Quarter 2013 Financial Results

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products marketed as...

Nov 05, 2013, 08:30 ET

BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2013 Financial Results on Tuesday, November 12, 2013

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Oct 23, 2013, 09:35 ET

BioSpecifics Technologies Corp. Announces Initiation of Phase 2a Study of XIAFLEX for Treatment of Cellulite

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Oct 07, 2013, 17:06 ET

BioSpecifics Technologies Corp. Announces Data from Multiple Studies of XIAFLEX for Treatment of Dupuytren's Contracture Presented at American Society for Surgery of the Hand 2013

 BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge